Rezolute (RZLT) Cash from Investing Activities (2012 - 2026)

Rezolute (RZLT) reported Cash from Investing Activities of $12.3 million for Q1 2026, down 46.73% on a YoY basis from $23.1 million in Q1 2025, and down 46.17% sequentially from $22.8 million in Q4 2025.

Rezolute (RZLT) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Rezolute (RZLT) has 13 years of Cash from Investing Activities data on file, last reported at $12.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 46.73% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at -$33.0 million (down 792.0% YoY), and the FY2025 full-year result was -$14.5 million, down 129.86% from the prior year.
  • Cash from Investing Activities declined to $12.3 million in Q1 2026, from $22.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $23.1 million in Q1 2025 to a low of -$95.0 million in Q1 2023.
  • A 5-year average of -$6.7 million and a median of $2.6 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities jumped 21497.59% in 2023 and tumbled 1996.01% in 2024, its largest moves.
  • Tracing RZLT's Cash from Investing Activities over 5 years: stood at -$83000.0 in 2022, then jumped by 21497.59% to $17.8 million in 2023, then slumped by 35.42% to $11.5 million in 2024, then soared by 98.92% to $22.8 million in 2025, then slumped by 46.17% to $12.3 million in 2026.
  • Business Quant data shows RZLT's Cash from Investing Activities at $12.3 million in Q1 2026, $22.8 million in Q4 2025, and -$68.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Rezolute 517.94 Mn 517.94 Mn - 12.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.28 Mn
Mar 31, 2026 12.28 Mn
Dec 31, 2025 22.81 Mn
Dec 31, 2025 22.81 Mn
Sep 30, 2025 -68.49 Mn
Sep 30, 2025 -68.49 Mn
Jun 30, 2025 346,000.00
Jun 30, 2025 346,000.00
Mar 31, 2025 23.05 Mn
Mar 31, 2025 23.05 Mn
Dec 31, 2024 11.47 Mn
Dec 31, 2024 11.47 Mn
Sep 30, 2024 -49.41 Mn
Sep 30, 2024 -49.41 Mn
Jun 30, 2024 19.66 Mn
Jun 30, 2024 19.66 Mn
Mar 31, 2024 8.67 Mn
Mar 31, 2024 8.67 Mn
Dec 31, 2023 17.76 Mn
Dec 31, 2023 17.76 Mn